Methyl aminolevulinate photodynamic therapy for Bowen's disease on the fingers-Is monotherapy sufficiently effective?
- PMID: 32623780
- PMCID: PMC7689839
- DOI: 10.1111/phpp.12586
Methyl aminolevulinate photodynamic therapy for Bowen's disease on the fingers-Is monotherapy sufficiently effective?
Conflict of interest statement
The authors MR, PW, and FJL received support from Galderma to attend Euro‐PDT‐meetings.
References
-
- Hansen JP, Drake AL, Walling HW. Bowen’s disease: a four‐year retrospective review of epidemiology and treatment at a university center. Dermatologic Surg. 2008;34(7):878‐883. - PubMed
-
- Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease) 2014. Br J Dermatol. 2014;170(2):245‐260. - PubMed
-
- Wong TW, Sheu HM, Lee JYY, Fletcher RJ. Photodynamic therapy for bowen’s disease (squamous cell carcinoma in situ) of the digit. Dermatologic Surg. 2001;27(5):452‐456. - PubMed
-
- Tan B, Sinclair R, Foley P. Photodynamic therapy for subungual Bowen’s disease. Australas J Dermatol. 2004;45(3):172‐174. - PubMed
-
- Souza CS, Felício L, Bentley MV et al Topical photodynamic therapy for Bowen’s disease of the digit in epidermolysis bullosa. Br J Dermatol. 2005;153(3):672‐674. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
